CCAAT/enhancer binding protein ␦ (C/EBP␦) plays a key role in mammary epithelial cell G 0 growth arrest, and "loss of function" alterations in C/EBP␦ have been reported in breast cancer and acute myeloid leukemia. C/EBP␦ is regulated at the transcriptional, post-transcriptional, and post-translational levels, suggesting tight control of C/EBP␦ content and function. Protein inhibitors of activated STATs (PIASs) regulate a growing number of transcription factors, including C/EBPs. HC11 nontransformed mammary epithelial cells express PIAS3, PIASx, and PIASy, and all three PIAS family members repress C/EBP␦ transcriptional activity. PIASy is the most potent, however, repressing C/EBP␦ transcriptional activity by >80%. PIASy repression of C/EBP␦ transcriptional activity is dependent upon interaction between the highly conserved PIASy N-terminal nuclear matrix binding domain (SAPD) and the C/EBP␦ transactivation domain (TAD). PIASy repression of C/EBP␦ transcriptional activity is independent of histone deacetylase activity, PIASy E3 SUMO ligase activity, and C/EBP␦ sumoylation status. PIASy expression is associated with C/EBP␦ translocation from nuclear foci, where C/EBP␦ co-localizes with p300, to the nuclear periphery. PIASy-mediated translocation of C/EBP␦ is dependent upon the PIASy SAPD and C/EBP␦ TAD. PIASy reduces the expression of C/EBP␦ adhesion-related target genes and enhances repopulation of open areas within a cell monolayer in the in vitro "scratch" assay. These results demonstrate that PIASy represses C/EBP␦ by a mechanism that requires interaction between the PIASy SAPD and C/EBP␦ TAD and does not require PIASy SUMO ligase activity or C/EBP␦ sumoylation. PIASy alters C/EBP␦ nuclear localization, reduces C/EBP␦ transcriptional activity, and enhances cell proliferation/migration.CCAAT/enhancer-binding protein ␦ (C/EBP␦) is a member of the highly conserved C/EBP 3 family of nuclear proteins (1).Six mammalian C/EBP family members have been identified, including C/EBP␣, C/EBP, C/EBP␥, C/EBP␦, C/EBP⑀, and C/EBP (CHOP10) (1). C/EBPs are highly conserved in evolution, with homologues identified in the sea slug (Aplysia californica (ApC/EBP)), zebrafish (Danio rerio (cebpd)), frog (Xenopus laevis (C/EBP␦-1 and -2)), and fruit fly (Drosophila melangaster (DmC/EBP)) (2-5). C/EBPs are characterized by conserved structural domains, including a transactivation domain (TAD), a regulatory domain, and highly conserved DNA binding (DB) and leucine zipper domains (LZ) (1). Although primarily recognized as transcriptional activators, C/EBP family members, including C/EBP␦, also function in protein-protein interactions with key cell cycle-regulatory proteins, such as Rb, p21, CDK2, and CDK4 (6 -9). Reports from our laboratory and others demonstrate that C/EBP␦ is regulated at the transcriptional, post-transcriptional, and post-translational levels (10 -17). At the transcriptional level, the C/EBP␦ gene promoter is induced by activated (phosphorylated) STAT3 (pSTAT3), Sp1, pCREB, and the transcriptional co-activator NcoA/...